Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Human Gene Therapy|June 20, 2020
Chorioallantoic Membrane Tumor Model for Evaluating Oncolytic VirusesLea Krutzke, Ellen Allmendinger, Katja Hirt, et al.
Elife|July 5, 2022
Process- and product-related impurities in the ChAdOx1 nCov-19 vaccineLea Krutzke, Reinhild Rösler, Ellen Allmendinger, et al.
Molecular Therapy. Oncology|January 6, 2025
An oncolytic HAdV-5 with reduced surface charge combines diminished toxicity and improved tumor targetingFrederik Wienen, Robin Nilson, Ellen Allmendinger, et al.
International Journal of Molecular Sciences|December 18, 2020
EGFR-Binding Peptides: From Computational Design towards Tumor-Targeting of Adeno-Associated Virus CapsidsRebecca C Feiner, Isabell Kemker, Lea Krutzke, et al.
Biomaterials Advances|November 28, 2022
Affilin-based retargeting of adenoviral vectors to the epidermal growth factor receptorFrederik Wienen, Robin Nilson, Ellen Allmendinger, et al.
Viruses|January 21, 2023
Evaluation of Human Mesenchymal Stromal Cells as Carriers for the Delivery of Oncolytic HAdV-5 to Head and Neck Squamous Cell CarcinomasRobin Nilson, Lea Krutzke, Frederik Wienen, et al.
International Journal of Molecular Sciences|June 10, 2023
Human Monocytes Are Suitable Carriers for the Delivery of Oncolytic Herpes Simplex Virus Type 1 In Vitro and in a Chicken Embryo Chorioallantoic Membrane Model of CancerAlberto Reale, Lea Krutzke, Massimiliano Cadamuro, et al.
Frontiers in Immunology|September 27, 2023
Heterologous DNA-prime/protein-boost immunization with a monomeric SARS-CoV-2 spike antigen redundantizes the trimeric receptor-binding domain structure to induce neutralizing antibodies in old miceDominik Pflumm, Alina Seidel, Fabrice Klein, et al.
Elife|January 27, 2022
Vaccine-induced COVID-19 mimicry syndromeEric Kowarz, Lea Krutzke, Marius Külp, et al.
Molecular Therapy. Methods & Clinical Development|April 11, 2022
Hexon modification of human adenovirus type 5 vectors enables efficient transduction of human multipotent mesenchymal stromal cellsRobin Nilson, Olivia Lübbers, Christoph Q Schmidt, et al.
Pageof 2